- ►annals.org HJ McQuay, RA Moore - Annals of Internal Medicine, 1997 - Am Coll Physicians Systematic reviews summarize large amounts of information and are more likely than individual
trials to describe the true clinical effect of an intervention.Traditional statistical outputs from systematic
reviews cannot immediately be applied to clinical practice. The number needed to treat ( ... Cited by 299 - Related articles - BL Direct - All 7 versions
ГД МакКуэй, РЭ Мур - mediasphera.ru В систематизированных обзорах суммируется большое количество информации, и истинный
клинический эффект любого вмешательства может быть представлен более
объективно, чем в отдельно взятых исследованиях. Статистические результаты ... Related articles
S EPIDEMOLOGICA - members.xoom.it Studi osservazionali Trasversali Caso-controllo Longitudinali (coorti) Studi sperimentali ... Il
BIAS di selezione di informazione di confondimento ... Il metodo random Randomizzazione
semplice Randomizzazione ristretta Blocchi permutati Stratificazione Minimizzazione ... Related articles - All 2 versions
A Laupacis, DL Sackett, RS Roberts - The New England journal of …, 1988 - ncbi.nlm.nih.gov 1: N Engl J Med. 1988 Jun 30;318(26):1728-33. An assessment of clinically useful
measures of the consequences of treatment. Laupacis A, Sackett DL, Roberts RS.
Department of Medicine, University of Western Ontario, London, Canada. ... Cited by 956 - Related articles - All 5 versions
- ►bmj.com DG Altman - British Medical Journal, 1998 - bmj.com Trials with binary end points yield a proportion of patients in each group with the outcome of
interest. When the outcome event is an adverse one, the difference between the proportions
with the outcome in the new treatment (p N ) and standard treatment (p S ) groups is ... Cited by 411 - Related articles - BL Direct - All 7 versions
- ►bmj.com RJ Cook, DL Sackett - British Medical Journal, 1995 - bmj.com The relative benefit of an active treatment over a control is usually expressed as the relative
risk, the relative risk reduction, or the odds ratio. These measures are used extensively in both
clinical and epidemiological investigations. For clinical decision making, however, it is ... Cited by 934 - Related articles - BL Direct - All 7 versions
G Chatellier, E Zapletal, D Lemaitre, J Menard, P … - British Medical Journal, 1996 - bmj.com The number needed to treat is a meaningful way of expressing the benefit of an active treatment
over a control. It can be used either for summarising the results of a therapeutic trial or for medical
decision making about an individual patient, but its use at the bedside has been impeded ... Cited by 171 - Related articles - BL Direct - All 6 versions
B FISHER - Biostatistics in clinical trials, 2001 - books.google.com 322 Number Needed to Treat (NNT) the high-risk patients, and lack of enthusiasm in the
low-risk patients. Cook & Sackett have suggested a method of rapidly calculating the NNT for
a patient with a different control event rate from the patients in a study [5]. If the baseline ... Related articles
L Wen, R Badgett, J Cornell - American journal of health-system pharmacy, 2005 - ASHP L ONNIE W EN , BSP HARM ., P H .D., is Clinical Education Consultant, Pfizer Inc., San
Antonio, TX; at the time of writing she was a fellow at VERDICT, South Texas Veterans Health
Care System (STVHCS), San Antonio. R OBERT B ADGETT , MD, is Clinical Professor, ... Cited by 13 - Related articles - BL Direct - All 9 versions
L Forrow, WC Taylor, RM Arnold - The American journal of medicine, 1992 - Elsevier : We conducted a survey of practicing physicians and of faculty and fellows in training programs
in clinical epidemiology and social science research methods. Each questionnaire presented
results from a published study of either hypertension or hypercholesterolemia in two ... Cited by 253 - Related articles - All 5 versions
